Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01445444 · ClinicalTrials.gov registry record · NA

Habit Reversal Training for Children and Adolescents With Trichotillomania

A NA study of Trichotillomania, sponsored by University of South Florida.

Completed
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT01445444 is a NA study of Trichotillomania that has completed, run by University of South Florida. The registered enrollment target is 50 participants, below the 66-participant average among 8 other Trichotillomania trials with a reported enrollment target (24% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01445444, a NA study of Trichotillomania, has completed, sponsored by University of South Florida.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The purpose of the current study is: 1. To evaluate the effectiveness of a habit reversal training (HRT) approach for children ages 7 to 17 years of age inclusive with a diagnosis of trichotillomania. 2. To explore factors that may relate to symptom severity, treatment outcome, and psychosocial impairment (e.g., specific symptom presence, co-morbidity, emotional regulation).

Conditions Studied

Interventions

  • BEHAVIORAL Habit Reversal Training

Study Locations (1)

Florida

  • Rothman Center for Pediatric Neuropsychiatry - St. Petersburg

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2011-09
Est. Completion 2016-03
Phase NA

Sponsor

University of South Florida

252 total trials

What the Registry Record Tells You About NCT01445444

The ClinicalTrials.gov registry entry for NCT01445444 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 66-participant average among 8 other Trichotillomania trials with a reported enrollment target (24% lower). The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Trichotillomania appearing as the primary indexed condition, and to 1 intervention - of which Habit Reversal Training is the first listed.

NCT01445444 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT01445444 about?

NCT01445444 is a clinical study titled "Habit Reversal Training for Children and Adolescents With Trichotillomania". The purpose of the current study is: 1. To evaluate the effectiveness of a habit reversal training (HRT) approach for children ages 7 to 17 years of age inclusive with a diagnosis of trichotillomania. 2. To explore factors that may relate to symptom severity, treatment outcome, and psychosocial imp...

What is the current status of trial NCT01445444?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2011-09. Estimated completion is 2016-03.

What conditions does trial NCT01445444 study?

This clinical trial studies the following conditions: Trichotillomania.

What interventions are being tested in trial NCT01445444?

The interventions under investigation include: Habit Reversal Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT01445444?

This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01445444 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Trichotillomania

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.